IN2014MN01871A - - Google Patents
Info
- Publication number
- IN2014MN01871A IN2014MN01871A IN1871MUN2014A IN2014MN01871A IN 2014MN01871 A IN2014MN01871 A IN 2014MN01871A IN 1871MUN2014 A IN1871MUN2014 A IN 1871MUN2014A IN 2014MN01871 A IN2014MN01871 A IN 2014MN01871A
- Authority
- IN
- India
- Prior art keywords
- riboflavin
- hydrates
- group
- relates
- present
- Prior art date
Links
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- -1 esters salts Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 235000019192 riboflavin Nutrition 0.000 abstract 1
- 239000002151 riboflavin Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/16—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring intraocular pressure, e.g. tonometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Ophthalmology & Optometry (AREA)
- Surgery (AREA)
- Biodiversity & Conservation Biology (AREA)
- Oncology (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Eye Examination Apparatus (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000355A ITMI20120355A1 (it) | 2012-03-07 | 2012-03-07 | Sostanza colorante per uso diagnostico oftalmologico |
| PCT/IB2013/051635 WO2013132396A1 (en) | 2012-03-07 | 2013-03-01 | Coloring substance for diagnostic ophtalmologic use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01871A true IN2014MN01871A (enrdf_load_stackoverflow) | 2015-07-03 |
Family
ID=45999982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1871MUN2014 IN2014MN01871A (enrdf_load_stackoverflow) | 2012-03-07 | 2013-03-01 |
Country Status (10)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202000017059A1 (it) * | 2020-07-14 | 2022-01-14 | Frastema Ophthalmics Easyopht Group Srl In Forma Abbreviata Fe Group Srl | Testa di applanazione monouso per tonometro ad applanazione |
| US11793891B2 (en) * | 2022-03-07 | 2023-10-24 | Opus Life Sciences, Llc | Fluorescein formulations and kits |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2603632A (en) * | 1949-04-06 | 1952-07-15 | American Cyanamid Co | Method of preparation of phosphoric acid esters of riboflavin |
| US5540227A (en) * | 1995-05-17 | 1996-07-30 | Poole; Thomas A. | Controlled application of select ophthalmic agents |
| DK1819366T4 (en) * | 2004-12-06 | 2016-09-12 | Univ Kyushu Nat Univ Corp | Staining to staining an ophthalmic membrane |
| WO2009042159A1 (en) * | 2007-09-24 | 2009-04-02 | The Johns Hopkins University | Wearable photoactivator for ocular therapeutic applications and use thereof |
| CA2805511C (en) * | 2009-07-27 | 2017-04-11 | Sanseverino, Renato | Ophthalmic solution for protecting internal structures of the eyeball against uv-a rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique |
| DE102009056597A1 (de) * | 2009-12-02 | 2011-06-09 | Tobias Brockmann | Verwendung von Flavin-Derivaten zur Behandlung von Pathologien an der Membrana limitans interna (ILM) |
| EP2392355A1 (en) * | 2010-06-03 | 2011-12-07 | Medical Technology Transfer Holding B.V. | Staining composition |
-
2012
- 2012-03-07 IT IT000355A patent/ITMI20120355A1/it unknown
-
2013
- 2013-03-01 BR BR112014022177A patent/BR112014022177A2/pt not_active Application Discontinuation
- 2013-03-01 IN IN1871MUN2014 patent/IN2014MN01871A/en unknown
- 2013-03-01 CA CA2900792A patent/CA2900792A1/en not_active Abandoned
- 2013-03-01 AU AU2013229096A patent/AU2013229096B2/en not_active Ceased
- 2013-03-01 WO PCT/IB2013/051635 patent/WO2013132396A1/en active Application Filing
- 2013-03-01 RU RU2014139766A patent/RU2639915C2/ru active
- 2013-03-01 EP EP13720041.6A patent/EP2822604B1/en active Active
-
2014
- 2014-09-03 US US14/476,062 patent/US9370587B2/en active Active
- 2014-10-06 ZA ZA2014/07224A patent/ZA201407224B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20140371569A1 (en) | 2014-12-18 |
| RU2639915C2 (ru) | 2017-12-25 |
| EP2822604B1 (en) | 2018-09-05 |
| AU2013229096A1 (en) | 2014-10-23 |
| CA2900792A1 (en) | 2013-09-12 |
| ZA201407224B (en) | 2016-05-25 |
| US9370587B2 (en) | 2016-06-21 |
| BR112014022177A2 (pt) | 2017-11-14 |
| ITMI20120355A1 (it) | 2013-09-08 |
| RU2014139766A (ru) | 2016-04-27 |
| AU2013229096B2 (en) | 2017-03-23 |
| EP2822604A1 (en) | 2015-01-14 |
| WO2013132396A1 (en) | 2013-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP4017A (en) | Substituted triazolopyridines and their use as ttk inhibitors | |
| EP3063262A4 (en) | Devices and methods for three-dimensional tissue culturing | |
| EP2901409A4 (en) | SYSTEMS AND METHOD FOR PRODUCING INVENTORIES FOR USE ON THE ROAD | |
| SG11201500606UA (en) | Patient interface and method for making same | |
| PT2874660T (pt) | Formulação oftálmica e respectivo uso e método para melhorar, reduzir ou tratar presbio-pia | |
| IL236678A0 (en) | Crystallin-alpha inhibitors for the treatment of cataracts | |
| SG11201504022RA (en) | Glutamase inhibitors and method of use | |
| EP3038646A4 (en) | Diagnostic methods and compositions for treatment of glioblastoma | |
| EP3003290A4 (en) | Compositions and methods for induced tissue regeneration in mammalian species | |
| EP3068758A4 (en) | Ebna1 inhibitors and their method of use | |
| SG11201510021TA (en) | Compositions and methods for use in medical diagnosis | |
| EP2820615A4 (en) | SYSTEM AND METHOD FOR THE PRODUCTION OF MEDICAL REPORTS | |
| EP3038663A4 (en) | Method of performing sterilization cycle | |
| SI2541503T1 (sl) | Postopek in sistem za merjenje obrobja RF-ZVEZE | |
| GB2517113B (en) | Method involving pre-treating medical instruments | |
| SG11201500503TA (en) | Apparatus for measuring the topography and thickness of the cornea and measuring method used | |
| IL239117A0 (en) | A method for metachromatic leukodystrophy diagnosis | |
| HUE044850T2 (hu) | Csúsztatható információs rendszer, valamint a rendszer információs eszközének elõállítási eljárása és alkalmazása | |
| IN2014MN01871A (enrdf_load_stackoverflow) | ||
| IL238934A0 (en) | Methods for the preparation of phenyloxymethyl-nitro-imidazole derivatives and their use | |
| HK40108466A (en) | Use of stearate in an inhalable formulation | |
| HK40105197A (en) | Use of stearate in an inhalable formulation | |
| AU2012901130A0 (en) | A composition and method for enhancing the permeability of a tissue of a subject to an active agent | |
| PT2749556T (pt) | Um processo melhorado para a preparação de ciamemazina pura e seus sais | |
| HK1224949A1 (en) | Plant-based composition for use in the treatment of cough |